CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,123 | -36.4% | 163,169 | +7.1% | 0.00% | – |
| Q2 2023 | $431,100 | +2661.0% | 152,332 | +4690.3% | 0.00% | – |
| Q1 2023 | $15,614 | -22.8% | 3,180 | +69.0% | 0.00% | – |
| Q4 2022 | $20,213 | +236.9% | 1,882 | +183.4% | 0.00% | – |
| Q3 2022 | $6,000 | -60.0% | 664 | -58.9% | 0.00% | – |
| Q2 2022 | $15,000 | -97.9% | 1,615 | -97.3% | 0.00% | – |
| Q1 2022 | $722,000 | +72100.0% | 59,442 | +141428.6% | 0.00% | – |
| Q4 2021 | $1,000 | -75.0% | 42 | -82.6% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 242 | -5.5% | 0.00% | – |
| Q2 2021 | $4,000 | +100.0% | 256 | +265.7% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 70 | +94.4% | 0.00% | – |
| Q4 2020 | $1,000 | -97.6% | 36 | -98.4% | 0.00% | – |
| Q3 2019 | $42,000 | -99.7% | 2,298 | -99.6% | 0.00% | -100.0% |
| Q2 2019 | $12,379,000 | +9.6% | 575,786 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $11,297,000 | +50.9% | 575,786 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,485,000 | -50.4% | 575,786 | -8.6% | 0.00% | -50.0% |
| Q3 2018 | $15,089,000 | +13.9% | 630,035 | -8.9% | 0.00% | 0.0% |
| Q2 2018 | $13,247,000 | +54.7% | 691,735 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $8,564,000 | -20.1% | 691,735 | -21.0% | 0.00% | 0.0% |
| Q4 2017 | $10,717,000 | -32.5% | 875,612 | -24.5% | 0.00% | -50.0% |
| Q3 2017 | $15,885,000 | -13.9% | 1,160,312 | -3.2% | 0.00% | 0.0% |
| Q2 2017 | $18,450,000 | +6.9% | 1,198,812 | +27.7% | 0.00% | 0.0% |
| Q1 2017 | $17,264,000 | +1943.1% | 938,776 | +931.6% | 0.00% | – |
| Q4 2016 | $845,000 | -91.5% | 90,999 | -94.3% | 0.00% | -100.0% |
| Q1 2016 | $9,904,000 | -84.8% | 1,592,261 | -58.9% | 0.00% | -88.9% |
| Q4 2015 | $65,350,000 | +17.3% | 3,876,023 | -0.6% | 0.01% | +12.5% |
| Q3 2015 | $55,726,000 | +295.6% | 3,899,623 | +236.3% | 0.01% | +300.0% |
| Q2 2015 | $14,088,000 | +20.9% | 1,159,541 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $11,653,000 | +0.8% | 1,159,541 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $11,561,000 | +6.9% | 1,159,541 | -10.0% | 0.00% | +100.0% |
| Q3 2014 | $10,810,000 | -59.6% | 1,288,410 | -18.1% | 0.00% | -75.0% |
| Q2 2014 | $26,773,000 | +0.3% | 1,573,054 | +9.7% | 0.00% | 0.0% |
| Q1 2014 | $26,681,000 | – | 1,433,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |